Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Getting through a Lifelong Change: Individual Examples of overcoming adversity - 2The most effective method to Settle on Informed Conclusions about Senior Insuranc.
- 3Israel approves death penalty law for Palestinians convicted of attacks
- 4Vote In favor of Your Favored Kind Of Organic product
- 5Get Cooking: 15 Speedy and Heavenly Recipes for Occupied Individuals
- Extravagance SUVs for Seniors: Solace, Innovation, and Security
- Highlight Correlation of Microsoft Surface Book and Surface Genius Workstations for Determination
- The Beginning Of The End For Fossil Fuels Can Start In Colombia
- Ocean side Locations for a Family Excursion
- Decrease in Home Buy Credits and Home loan Renegotiating Rates: An Outline of Latest things
- Man Charged for Stealing ‘Incredibly Precious’ 286-Year-Old Violin, Worth More Than $200,000, from a Tavern
- Haifa refinery said hit in latest Iranian missile barrage
- What an expert on the gut microbiome eats in a day
- Purchases of iPhone 17 Pro soar across Gaza amid 'limited' humanitarian aid
